Company Filing History:
Years Active: 2020
Title: The Innovations of Pascal Benderitter
Introduction
Pascal Benderitter is a notable inventor based in St. Apollinaire, France. He has made significant contributions to the field of biotechnology, particularly in the development of kinase inhibitors. His work focuses on creating innovative solutions for medical applications.
Latest Patents
Benderitter holds a patent for "Macrocyclic RIP2 kinase inhibitors." This invention relates to macrocyclic compounds and compositions that act as kinase inhibitors, specifically targeting RIP2 and its mutants. The patent outlines the use of these compounds in the diagnosis, prevention, and treatment of diseases associated with RIP2 kinase. Additionally, it provides methods for utilizing these compounds as medicines or diagnostic agents.
Career Highlights
Pascal Benderitter is associated with Oncodesign SA, a company that specializes in drug discovery and development. His work at Oncodesign has allowed him to focus on innovative research that has the potential to impact the medical field significantly.
Collaborations
Benderitter collaborates with esteemed colleagues such as Jan Hoflack and Petra Blom. Their combined expertise contributes to the advancement of research and development in their respective fields.
Conclusion
Pascal Benderitter's contributions to the field of biotechnology through his innovative patent on RIP2 kinase inhibitors highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments and diagnostics.